These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11589181)

  • 1. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE.
    Shin KC; Lee YJ; Kang SW; Baek HJ; Lee EB; Kim HA; Song YW
    Ann Rheum Dis; 2001 Oct; 60(10):988-9. PubMed ID: 11589181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Procalcitonin as a biomarker in patients with systemic lupus erythematosus].
    Consiglio FJ; Ordi Ros J
    Med Clin (Barc); 2013 Mar; 140(5):214-6. PubMed ID: 23276619
    [No Abstract]   [Full Text] [Related]  

  • 3. [Procalcitonin and neonatal infection].
    Kuhn P; Escande B; Rivera S; Langlet C; Messer J
    Arch Pediatr; 2004 Jun; 11(6):585-6. PubMed ID: 15158843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proper usage of procalcitonin].
    Green Y; Petignat PA; Perrier A
    Rev Med Suisse; 2007 Oct; 3(129):2330-2, 2334. PubMed ID: 18018823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
    Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
    J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS.
    Echeverri A; Naranjo-Escobar J; Posso-Osorio I; Aguirre-Valencia D; Zambrano D; Castaño GL; Martínez JD; Cañas CA; Tobón GJ
    Lupus; 2018 Jun; 27(7):1130-1139. PubMed ID: 29540108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin as a marker for postoperative complications.
    Haane C; Mardin WA; Irmscher S; Senninger N; Schleicher C; Mees ST
    Clin Lab; 2010; 56(3-4):153-4; author reply 154-5. PubMed ID: 20476648
    [No Abstract]   [Full Text] [Related]  

  • 8. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.
    Serio I; Arnaud L; Mathian A; Hausfater P; Amoura Z
    Clin Rheumatol; 2014 Sep; 33(9):1209-15. PubMed ID: 25064130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
    Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
    Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
    Eberhard OK; Haubitz M; Brunkhorst FM; Kliem V; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Jul; 40(7):1250-6. PubMed ID: 9214425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procalcitonin--acute inflammatory marker in infections].
    Tvede M
    Ugeskr Laeger; 2004 Oct; 166(43):3795. PubMed ID: 15544106
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
    Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
    Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
    Bador KM; Intan S; Hussin S; Gafor AH
    Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of procalcitonin at the pediatric emergency room].
    Gendrel D
    Arch Pediatr; 2004 Jun; 11(6):582-4. PubMed ID: 15158842
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus.
    Hind CR; Ng SC; Feng PH; Pepys MB
    Ann Rheum Dis; 1985 Apr; 44(4):260-1. PubMed ID: 3985691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin Is Not Useful to Discriminate Between Infectious and Noninfectious CRP Elevation in Patients with Non-Small Cell Lung Cancer.
    Scheinpflug K; Schalk E; Grabert E; Achenbach HJ
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1117-8. PubMed ID: 26006190
    [No Abstract]   [Full Text] [Related]  

  • 18. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.
    Brunkhorst R; Eberhardt OK; Haubitz M; Brunkhorst FM
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S199-201. PubMed ID: 18470720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin: a new marker for diagnosis of acute rejection and nonviral infection of heart and lung transplant patients.
    Hammer C; Fraunberger P; Meiser B; Hammer S
    Transplant Proc; 2001 May; 33(3):2204-6. PubMed ID: 11377503
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.